The store will not work correctly when cookies are disabled.
(+/-)-2-(5,6-dihydroimidazo[2,1-b]thiazol-6-yl)benzo[b]thiophen-5-amine hydrochloride
ID: ALA3092294
PubChem CID: 72737031
Max Phase: Preclinical
Molecular Formula: C13H12ClN3S2
Molecular Weight: 273.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cl.Nc1ccc2sc(C3CN4C=CSC4=N3)cc2c1
Standard InChI: InChI=1S/C13H11N3S2.ClH/c14-9-1-2-11-8(5-9)6-12(18-11)10-7-16-3-4-17-13(16)15-10;/h1-6,10H,7,14H2;1H
Standard InChI Key: AAYUGJSPDGFFSN-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
12.3330 -4.5320 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
10.7094 -5.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5007 -6.9404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0768 -5.6078 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.5016 -5.8672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5071 -6.6941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2882 -5.8598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1952 -6.2702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0217 -6.2676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7137 -6.9401 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.5149 -5.6016 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9270 -6.6902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0746 -6.9425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5637 -6.2765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2132 -5.4555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2201 -7.1013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2892 -6.6925 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9256 -5.8664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7838 -5.4577 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5 6 1 0
10 8 1 0
6 16 2 0
15 5 2 0
12 18 2 0
11 7 2 0
17 7 1 0
9 8 1 0
14 13 2 0
18 15 1 0
3 9 1 0
14 4 1 0
4 7 1 0
2 18 1 0
3 17 1 0
8 2 2 0
9 11 1 0
12 10 1 0
16 12 1 0
13 17 1 0
5 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 273.39 | Molecular Weight (Monoisotopic): 273.0394 | AlogP: 3.41 | #Rotatable Bonds: 1 |
Polar Surface Area: 41.62 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.12 | CX LogP: 2.48 | CX LogD: 2.48 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.81 | Np Likeness Score: -0.91 |
References
1. Debray J, Chang L, Marquès S, Pellet-Rostaing S, Le Duy D, Mebarek S, Buchet R, Magne D, Popowycz F, Lemaire M.. (2013) Inhibitors of tissue-nonspecific alkaline phosphatase: design, synthesis, kinetics, biomineralization and cellular tests., 21 (24): [PMID:24183741] [10.1016/j.bmc.2013.09.053] |